Moderna Takes The Lead With Plan To Tackle New COVID-19 Variants

New Tweaked Booster To Enter Phase I Study

Moderna has unveiled plans to develop a new booster vaccine, tweaked to meet the threat posed by the South African strain.

Moderna aims to produce up to 1 billion doses of its existing vaccine in 2021 - but a new booster to target variants will also enter Phase I trials.

More from Anti-infective

More from Therapy Areas